Cardinal Capital Management Inc (North Carolina)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.05M Buy
105,075
+568
+0.5% +$32.6K 0.73% 45
2026
Q1
$6.34M Buy
104,507
+219
+0.2% +$12.8K 0.82% 45
2025
Q4
$5.63M Buy
104,288
+1,075
+1% +$51.7K 0.75% 47
2025
Q3
$4.65M Buy
103,213
+2,140
+2% +$99.9K 0.64% 54
2025
Q2
$4.68M Buy
101,073
+3,414
+3% +$168K 0.69% 51
2025
Q1
$5.96M Buy
97,659
+2,625
+3% +$153K 0.92% 35
2024
Q4
$5.38M Buy
95,034
+353
+0.4% +$19.7K 0.84% 40
2024
Q3
$4.9M Buy
+94,681
New +$4.44M 0.76% 45
2024
Q2
Sell
-56,860
Closed -$3.08M 136
2024
Q1
$3.08M Buy
56,860
+6,210
+12% +$316K 0.5% 64
2023
Q4
$2.6M Buy
50,650
+15,087
+42% +$792K 0.49% 68
2023
Q3
$2.06M Buy
35,563
+1,070
+3% +$65.6K 0.42% 72
2023
Q2
$2.21M Buy
+34,493
New +$2.31M 0.44% 71

Other funds holding BMY

Cardinal Capital Management Inc (North Carolina)'s BMY Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Bristol-Myers Squibb (BMY) stake by 0.54% in Q2 2026, buying an estimated $32.6K and bringing the position to 105,075 shares worth $6.05M. The position accounts for 0.73% of the portfolio, ranked #45.

Cardinal Capital Management Inc (North Carolina) first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.34M in Q1 2026. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 105,075 shares of Bristol-Myers Squibb worth $6.05M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 568 Bristol-Myers Squibb shares in Q2 2026, an estimated $32.6K.
  • Bristol-Myers Squibb made up 0.73% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #45 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s Bristol-Myers Squibb position peaked at $6.34M in Q1 2026.
  • 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.